跳至主要内容
临床试验/ACTRN12621000072819
ACTRN12621000072819尚未招募未知

Effect of a marine extract on body composition and strength in healthy middle-aged persons using a randomised, double-blinded design

Pharmalink International Pty Ltd0 个研究点目标入组 100 人开始时间: 2021年1月29日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 65 Years(—)
性别
All

入选标准

  • Not physically or mentally impacted by a severe acute or chronic medical condition
  • Persons with Type 2 diabetes, well-controlled with or without medication, for greater than six months, will be eligible
  • Persons on stable blood pressure or lipid medication for greater than three months will be eligible as long there is no diagnosis of a major cardiovascular disease.
  • BMI greater than 18 and less than 35

排除标准

  • Having a pacemaker or other metallic implants
  • Smokers, including vaping
  • Allergy to shellfish, green-lipped mussels or Antarctic krill
  • Pregnant or breast-feeding or planning to become pregnant in the next 6 months.
  • Alcohol or drug addiction.
  • Inability to cease taking current alternative medicines for the duration of the trial.
  • Persons with kidney disease or impaired kidney function
  • Persons with oedema
  • Persons with severe vertigo

研究者

发起方
Pharmalink International Pty Ltd

相似试验